Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04492943 · ClinicalTrials.gov registry record
To Observe Whether Isoflurane Can Treat COVID-19 Patients
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 35
- Enrollment target
NCT04492943: Completed study, sponsored by Massachusetts General Hospital.
NCT04492943 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04492943 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
This is a blood collection and retrospective data collection study. The investigators plan to assess whether the sedative drug, isoflurane, can treat COVID-19 patients relatively better compared to other sedative drugs given during routine treatment to patients on mechanical ventilation. The investigators will also use nanoneedle biosensors to quickly detect blood IgM/IgG ratio in those patients, and (3) to establish a pre-clinical system to determine the effects of inhalational anesthetics on amounts of SARS-CoV-2 and other viruses, and pneumoniae.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2020-04-20 |
| Est. Completion | 2020-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04492943
The ClinicalTrials.gov registry entry for NCT04492943 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04492943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04492943 about?
NCT04492943 is a clinical study titled "To Observe Whether Isoflurane Can Treat COVID-19 Patients". This is a blood collection and retrospective data collection study. The investigators plan to assess whether the sedative drug, isoflurane, can treat COVID-19 patients relatively better compared to other sedative drugs given during routine treatment to patients on mechanical ventilation. The investi...
What is the current status of trial NCT04492943?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2020-04-20. Estimated completion is 2020-06-30.
Who is sponsoring clinical trial NCT04492943?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.